RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1357
Malaria parasiteP. berghei
Genotype
Transgene
Transgene not Plasmodium: 2 zinc-finger nucleases (ZFNL, ZFNLR)
Promoter: Gene model: PBANKA_1003000; Gene model (P.falciparum): PF3D7_0405300; Gene product: liver specific protein 2, putative | sequestrin | 6-cysteine protein (LISP2)
3'UTR: Gene model: PBANKA_1340000; Gene product: dihydrofolate synthase/folylpolyglutamate synthase, putative (PbDHFS-FPGS)
Replacement locus: Gene model: Not available; Gene product: Not available
Transgene
Transgene not Plasmodium: a fusion of GFP and hdhfr
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: Not available; Gene product: Not available
Phenotype Liver stage;
Last modified: 23 November 2015, 19:10
  *RMgm-1357
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 26573820
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherSinger M; Frischknecht F
Name Group/DepartmentIntegrative Parasitology, Center for Infectious Diseases
Name InstituteUniversity of Heidelberg Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1357
Principal nameLs2ZFN
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageSeveral mice infected with Ls2ZFN sporozoites developed a blood stage infection, indicating that expression of the ZFNs in late liver stages did not lead to (complete) cell death (see below).
Additional remarks phenotype

Mutant/mutation
The mutant expresses two zinc-finger nucleases specific for eGFP (ZFNL, ZFNLR) under control of the liver-stage specific promoter lisp2 and expresses GFP under control of the constitutive eef1a promoter.
Both zfn genes were separated by the self-cleaving 2A skip peptide from Thosea asigna virus, which has been shown to lead to efficient self-cleavage resulting in expression of two genes in P. falciparum.
To avoid HR between both zfn genes, the zfnL was codon-modified to zfnLcm to have the lowest possible homology with zfnR. This was accomplished by first codon-optimizing zfnL for P. berghei codon usage and then manually changing all codons still identical to zfnR whenever possible.
A silent point mutation is introduced in egfp (mgfp)
The transgene casette is integrated into a silent locus on chromosome 12 (see RMgm-1023).

Protein (function)
The aim is to introduce double-strand breaks (DSB) through well-timed and tightly regulated expression of zinc-finger nucleases (ZFNs), that in the absence of the NHEJ machinery or a plasmid repair template for HR — cannot repair and thus will result in cell death.
Genetic modification in Plasmodium utilises transfection of plasmid DNA and its exclusive integration via homologous recombination (HR) in blood stage parasites. In contrast, the related apicomplexan parasite Toxoplasma gondii mainly employs non-homologous end joining (NHEJ) as the primary DNA repair pathway. In this species genes involved in the NHEJ pathway, including Ku70/80, were readily identified. A T. gondii parasite line lacking Ku80 can only perform HR, thus allowing efficient targeted gene modification via HR. Genes involved in NHEJ have so far not been identified in any Plasmodium species. Also, recent data suggest that alternative DNA repair can occur in P. falciparum

Phenotype
Several mice infected with Ls2ZFN sporozoites developed a blood stage infection, indicating that expression of the ZFNs in late liver stages did not lead to (complete) cell death. It is proposed that parasites excaped DSB by HR or non-timely ZFN expression. See also RMgm-1358, RMgm-1359 and RMgm-1360 for mutants expressing the ZFNs under control of sporozoite specific promoters resulting in a  strongly reduced infectivity of sporozoites.
In the paper the genotype of parasites of 'breakthrough blood-infections' is analysed and evidence is provided for DNA repair by microhomology-mediated end joining with as little as four base pairs, resulting in surviving parasites.

Additional information

Other mutants
See RMgm-1357, RMgm-1358, RMgm-1359, RMgm-1360 for GFP-expressing mutants that express the two ZFNs under control of different promoters


  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene name2 zinc-finger nucleases (ZFNL, ZFNLR)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThis description below describes vectors for mutants Rmgm-1357, Rmgm-1358 and Rmgm-1359.

All vectors used for this study were derived from Pb237. The following modifications were made. A 565-bp upstream region of ef1α was amplified from P. berghei ANKA WT gDNA with P5/P6 and cloned with AgeI/ApaI to replace the promoter sequence driving the selection marker. The hdhfr gene was amplified from human cDNA with P7/P8 and cloned with AgeI/NheI. Next egfp was amplified with P9/P10 and cloned upstream in frame with hdhfr with AgeI to result in an egfp-hdhfr fusion gene (Pb238). To generate the expression box for the ZFNs, subcloning was performed in pGEM. The promoter of CSP was amplified with P11/P12 and cloned into pGEM. zfnL was amplified with P13/P14 and inserted with KpnI/PshAI, followed by insertion of the 3’ UTR of csp (P15/P16) with PshAI/SwaI. In parallel, the fragments of the 3’ UTR of dhfs, zfnR and TRAP promoter were amplified with P17/P18, P19/20 and P21/P22, respectively, cloned into pGEM with direct ligation, PshAI/KpnI and SwaI/PshAI, and cloned with EcoRV/SwaI into the first pGEM vector. The whole fragment was cloned with NotI/EvoRV into Pb238, resulting in the vector SpZFN. To generate LsZFN, the promoter of lisp2 was amplified with P23/P24, zfnL was amplified with P25/P26, introducing the 2A skip peptide via P26. Both PCR products were fused with overlap extension PCR using P23/P26 and cloned into SpZFN with NotI/PshAI. To generate mgfp for the following vectors, two fragments of egfp were amplified with P27/P28 and P29/P30, fused with overlap extension PCR P27/P30 and cloned into LsZFN with SwaI/PstI. The zfnL gene was codon-modified with the codon usage table from P. berghei (http://www.kazusa.or.jp.codon/) that was applied with OPTIMIZER (http://genomes.urv.es/OPTIMIZER/). The resulting coding sequence was aligned with zfnR and in all identical codons a silent mutation was introduced wherever possible, resulting in an additional 21 bp changed. The resulting sequence, zfnLcm with fused 2A skip peptide, was ordered from GeneArt (Regensburg). The promoter of csp/lisp2 was amplified with P31/P32 and P33/P34, cloned via NotI/HindIII into zfnLcm and together with zfnLcm cloned into LsZFN (mgfp) with NotI PshAI, resulting in Sp2ZFN and Ls2ZFN, respectively. To generate TrapZFN and Uis4ZFN, the respective promoter regions were amplified with P35/P36 and P37/P38, and cloned with NotI/NdeI into Sp2ZFN.
All vectors were linearised with PvuI prior to transfection and integrated into chromosome 12 between bases 846,483 and 847,711 using two homology regions, Chr12a and Chr12b, with lengths of 481 and 431 bp, respectively.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1003000
Gene Model P. falciparum ortholog PF3D7_0405300
Gene productliver specific protein 2, putative | sequestrin | 6-cysteine protein
Gene product: Alternative nameLISP2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1340000
Gene productdihydrofolate synthase/folylpolyglutamate synthase, putative
Gene product: Alternative namePbDHFS-FPGS
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene namea fusion of GFP and hdhfr
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4